A molecular toolbox to study progesterone receptor signaling.


Journal

Journal of mammary gland biology and neoplasia
ISSN: 1573-7039
Titre abrégé: J Mammary Gland Biol Neoplasia
Pays: United States
ID NLM: 9601804

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 20 07 2023
accepted: 29 10 2023
medline: 30 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Progesterone receptor (PR) signaling is required for mammary gland development and homeostasis. A major bottleneck in studying PR signaling is the lack of sensitive assays to measure and visualize PR pathway activity both quantitatively and spatially. Here, we develop new tools to study PR signaling in human breast epithelial cells. First, we generate optimized Progesterone Responsive Element (PRE)-luciferase constructs and demonstrate that these new reporters are a powerful tool to quantify PR signaling activity across a wide range of progesterone concentrations in two luminal breast cancer cell lines, MCF7 and T47D. We also describe a fluorescent lentiviral PRE-GFP reporter as a novel tool to visualize PR signaling at the single-cell level. Our reporter constructs are sensitive to physiological levels of progesterone. Second, we show that low background signaling, and high levels of PR expression are a prerequisite for robustly measuring PR signaling. Increasing PR expression by transient transfection, stable overexpression in MCF7 or clonal selection in T47D, drastically improves both the dynamic range of luciferase reporter assays, and the induction of endogenous PR target genes as measured by qRT-PCR. We find that the PR signaling response differs per cell line, target gene and hormone concentration used. Taken together, our tools allow a more rationally designed approach for measuring PR signaling in breast epithelial cells.

Identifiants

pubmed: 38019315
doi: 10.1007/s10911-023-09550-0
pii: 10.1007/s10911-023-09550-0
pmc: PMC10687192
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Receptors, Progesterone 0
Luciferases EC 1.13.12.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : OCENW.KLEIN.169

Informations de copyright

© 2023. The Author(s).

Références

Nat Genet. 2017 Mar;49(3):444-450
pubmed: 28112739
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2989-94
pubmed: 20133621
Int J Cancer. 1995 Mar 29;61(1):80-6
pubmed: 7705937
In Vitro. 1976 Jan;12(1):23-30
pubmed: 1244327
J Biol Chem. 2002 Feb 15;277(7):5209-18
pubmed: 11717311
Eur J Biochem. 1999 Jan;259(1-2):385-95
pubmed: 9914518
Anal Biochem. 2006 Sep 1;356(1):94-9
pubmed: 16750160
Mol Cell Biol. 2000 May;20(9):3102-15
pubmed: 10757795
Mol Endocrinol. 1994 Oct;8(10):1347-60
pubmed: 7854352
Sci Transl Med. 2013 Dec 11;5(215):215le4
pubmed: 24337478
Nucleic Acids Res. 2021 Dec 16;49(22):12716-12731
pubmed: 34850111
Mol Cell Biol. 2004 Dec;24(24):10542-57
pubmed: 15572662
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6508-13
pubmed: 27155014
Nature. 2010 Jun 10;465(7299):803-7
pubmed: 20445538
Horm Cancer. 2018 Aug;9(4):265-277
pubmed: 29736565
Genes Dev. 2000 Mar 15;14(6):650-4
pubmed: 10733525
Cancer Res. 1999 Jan 15;59(2):372-6
pubmed: 9927049
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496-500
pubmed: 3458212
Mol Endocrinol. 2009 Jul;23(7):989-1000
pubmed: 19372234
Breast Cancer Res. 2016 Sep 20;18(1):92
pubmed: 27650553
Cell. 1988 May 6;53(3):371-82
pubmed: 2835167
J Virol. 1998 Nov;72(11):8463-71
pubmed: 9765382
Mol Endocrinol. 2003 Apr;17(4):628-42
pubmed: 12554776
Endocrinology. 2009 Jul;150(7):3318-26
pubmed: 19342456
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
BMC Bioinformatics. 2021 Sep 10;22(1):433
pubmed: 34507520
Science. 2015 Oct 16;350(6258):325-8
pubmed: 26472909
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5076-81
pubmed: 9560231
Steroids. 2005 May-Jun;70(5-7):418-26
pubmed: 15862825
Mol Endocrinol. 2007 Feb;21(2):359-75
pubmed: 17138644
Mol Endocrinol. 2013 Oct;27(10):1743-61
pubmed: 23979845
Cancer Lett. 2016 May 1;374(2):279-91
pubmed: 26892043
Nucleic Acids Res. 2019 Feb 28;47(4):e23
pubmed: 30590691
Genes Dev. 1995 Sep 15;9(18):2266-78
pubmed: 7557380
J Mol Endocrinol. 2020 Jul;65(1):T81-T94
pubmed: 32508307
Sci Transl Med. 2013 Apr 24;5(182):182ra55
pubmed: 23616122
Mol Endocrinol. 1993 Apr;7(4):515-27
pubmed: 8388996
Essays Biochem. 2021 Dec 17;65(6):847-856
pubmed: 34825698
J Mammary Gland Biol Neoplasia. 2023 Jul 14;28(1):17
pubmed: 37450065
EMBO J. 1990 May;9(5):1603-14
pubmed: 2328727
Exp Cell Res. 2014 Nov 1;328(2):351-60
pubmed: 25172557
ACS Synth Biol. 2016 May 20;5(5):395-404
pubmed: 26883397
Mol Cell. 2006 Nov 3;24(3):367-81
pubmed: 17081988
Proc Natl Acad Sci U S A. 1987 Nov;84(22):7871-5
pubmed: 2891134
Reprod Sci. 2018 Feb;25(2):214-221
pubmed: 28671036
J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65
pubmed: 15601642
Mol Cell Biochem. 2016 Nov;422(1-2):109-120
pubmed: 27632388
Toxicol Sci. 2011 Oct;123(2):511-22
pubmed: 21775728
Mol Endocrinol. 1988 Mar;2(3):263-71
pubmed: 3398853
Mol Cell Biol. 2005 Apr;25(8):2885-98
pubmed: 15798179
RNA. 2003 Apr;9(4):493-501
pubmed: 12649500
J Pathol Clin Res. 2017 Oct 10;3(4):227-233
pubmed: 29085663
Proc Natl Acad Sci U S A. 1970 Oct;67(2):501-8
pubmed: 5289005
Methods Mol Biol. 2008;468:99-110
pubmed: 19099249
J Biol Chem. 2012 Oct 5;287(41):34809-24
pubmed: 22891251
Front Physiol. 2022 Mar 16;13:826107
pubmed: 35399282
Nature. 2015 Jul 16;523(7560):313-7
pubmed: 26153859
J Clin Invest. 2015 Apr;125(4):1603-19
pubmed: 25751063
Mol Endocrinol. 2016 Feb;30(2):158-72
pubmed: 26652902

Auteurs

Marleen T Aarts (MT)

Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands.

Muriel Wagner (M)

Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands.

Tanne van der Wal (T)

Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands.

Antonius L van Boxtel (AL)

Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands.

Renée van Amerongen (R)

Developmental, Stem Cell and Cancer Biology, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands. r.vanamerongen@uva.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH